Monsenso signs large commercial order with private, international healthcare provider
19.3.2026 16:39:21 CET | Monsenso | Company Announcement
Company Announcement no. 02-2026
Copenhagen, 2026.03.19
This message includes inside information
In our 2025 annual report (note 2), we mentioned that negotiation of an order was in the final stage. That order has now been signed. It does not change our revenue expectations for 2026, but it reduces the financial risks we mentioned. We also plan to raise additional capital in the second quarter of 2026.
As part of the agreement, Monsenso is configuring and delivering its digital health platform for an international, private healthcare provider. The platform will be used to collect patient-reported data, support medication adjustments, provide patients with information about their treatment and medication, facilitate communication between patients and healthcare providers, and deliver more personalised remote care.
“The potential of this agreement is significant. It includes an initial order to set up and configure the platform, and it will bring in recurring revenue in the future. There is also strong potential to expand into other disease areas already covered by the customer” says Thomas Lethenborg, CEO of Monsenso.
Further information:
Monsenso
CEO
Thomas Lethenborg
Tel. +45 21 29 88 27
E-mail: lethenborg@monsenso.com
Chairman of the board
Peter Mørch Eriksen
E-mail: Petermorcheriksen@outlook.com
Certified Adviser:
HC Andersen Capital
Bredgade 23,
1260 København
About Monsenso
Monsenso is an innovative technology company offering a digital health solution used for decentralised trials, remote patient monitoring and treatment support. Our mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data. Our solution helps optimise the treatment and gives a detailed overview of an individual’s health through the collection of outcome, adherence and behavioral data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. We collaborate with health and social care, pharmaceuticals and leading researcher worldwide in our endeavors to deliver solutions that fit into the lives of patients and health care professionals. To learn more visit www.monsenso.com
Alternative languages
Attachments
Subscribe to our company announcements
Keep up to date with our company announcements by subscribing.
Visit our pressroom and see more company announcements from us.
Our pressroom